ELI
EXAS

Empire Life Investments’s Exact Sciences EXAS Stock Holding History

Empire Life Investments’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-187,740
Closed -$19.1M – 115
2025
Q4 		$19.1M Sell
187,740
-161,826
-46% -$13M 1.07% 32
2025
Q3 		$19.1M Buy
349,566
+80,657
+30% +$4.03M 1.12% 34
2025
Q2 		$14.3M Sell
268,909
-24,969
-8% -$1.27M 0.91% 41
2025
Q1 		$12.7M Buy
293,878
+51,113
+21% +$2.59M 0.83% 46
2024
Q4 		$13.6M Sell
242,765
-5,933
-2% -$369K 0.86% 44
2024
Q3 		$16.9M Sell
248,698
-2,389
-1% -$135K 1.03% 40
2024
Q2 		$10.6M Sell
251,087
-10,036
-4% -$552K 0.67% 52
2024
Q1 		$18M Sell
261,123
-2,566
-1% -$162K 1.11% 35
2023
Q4 		$19.5M Buy
263,689
+41,174
+19% +$2.7M 1.26% 30
2023
Q3 		$15.2M Buy
222,515
+64,301
+41% +$5.46M 1.11% 35
2023
Q2 		$14.9M Sell
158,214
-336
-0.2% -$26.2K 1.01% 39
2023
Q1 		$10.8M Buy
158,550
+1,550
+1% +$99.6K 0.76% 45
2022
Q4 		$7.77M Sell
157,000
-1,728
-1% -$70.6K 0.53% 49
2022
Q3 		$5.16M Buy
158,728
+5,207
+3% +$215K 0.39% 56
2022
Q2 		$6.05M Buy
153,521
+3,124
+2% +$167K 0.44% 52
2022
Q1 		$10.5M Buy
150,397
+26
+0% +$1.9K 0.67% 46
2021
Q4 		$11.7M Buy
150,371
+1,628
+1% +$144K 0.71% 44
2021
Q3 		$14.2M Buy
148,743
+1,433
+1% +$151K 0.93% 39
2021
Q2 		$18.3M Buy
147,310
+8,204
+6% +$979K 1.18% 31
2021
Q1 		$18.3M Sell
139,106
-2,105
-1% -$288K 1.26% 30
2020
Q4 		$18.7M Sell
141,211
-61,924
-30% -$7.49M 1.32% 28
2020
Q3 		$20.7M Buy
203,135
+629
+0.3% +$54.3K 1.66% 22
2020
Q2 		$17.6M Sell
202,506
-10,209
-5% -$816K 1.55% 26
2020
Q1 		$12.3M Buy
212,715
+103,755
+95% +$8.42M 1.13% 31
2019
Q4 		$10.1M Buy
+108,960
New +$9.58M 0.77% 44
2018
Q2 		– Sell
-88,650
Closed -$3.58M – 103
2018
Q1 		$3.58M Buy
+88,650
New +$4.32M 0.25% 83

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Empire Life Investments's EXAS Position: Q1 2026 in Review

Empire Life Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 187,740 shares — an estimated $19.1M sold.

Empire Life Investments first reported a position in EXAS in Q1 2018 and held it in 26 quarters. The position peaked at $20.7M in Q3 2020. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Empire Life Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Empire Life Investments sold 187,740 Exact Sciences shares in Q1 2026, an estimated $19.1M.
  • Empire Life Investments first reported a position in Exact Sciences in Q1 2018 and held it in 26 quarters.
  • Empire Life Investments's Exact Sciences position peaked at $20.7M in Q3 2020.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Empire Life Investments's 13F filing for Q1 2026, filed 11 May 2026.